Medicine and Dentistry
Adjuvant Chemotherapy
10%
Adjuvant Endocrine Therapy
6%
Adjuvant Therapy
11%
Adverse Event
6%
Antiretroviral Therapy
8%
Arm
9%
Aromatase Inhibitor
12%
Arthralgia
7%
Biological Marker
8%
Breast Cancer
100%
Cancer Adjuvant Therapy
19%
Cancer Therapy
6%
Cervical Intraepithelial Neoplasia
7%
Complementary and Alternative Medicine
12%
Computer Assisted Tomography
7%
Diseases
18%
DNA Adduct
6%
Glucosamine
6%
Health Care
8%
Hematinic
12%
Hormone Receptor
11%
Hormone Therapy
18%
Human Immunodeficiency Virus
45%
Laryngeal Mask Airway
6%
Lopinavir
10%
Lymph Node
6%
Malignant Neoplasm
37%
Medicare
16%
Myelodysplastic Syndrome
6%
Neoplasm
26%
Nevirapine
24%
Odds Ratio
17%
Oncologist
7%
Open-Label Trial
6%
Ovarian Cancer
6%
Patient Social Context
7%
Placebo
8%
Polycyclic Aromatic Hydrocarbon
18%
Prevalence
8%
Prospective Cohort Study
13%
Proteinase Inhibitor
18%
Quality of Life
12%
Randomized Clinical Trial
12%
Randomized Controlled Trial
18%
Ritonavir
9%
Side Effect
7%
Stavudine
6%
Surgeon
6%
Tracheal Intubation
6%
Wart Virus
18%
Pharmacology, Toxicology and Pharmaceutical Science
8 Hydroxydeoxyguanosine
6%
Abacavir
6%
Acute Myeloid Leukemia
6%
Adverse Event
6%
Aflatoxin
16%
Aflatoxin B1
24%
Alzheimer's Disease
6%
Antianemic Agent
6%
Biological Marker
9%
Breast Cancer
37%
Carcinogen
9%
Chemotherapy
13%
Chronic Hepatitis B
8%
Developmental Effect
6%
Diseases
14%
Efavirenz
6%
Granulocyte Colony Stimulating Factor
6%
Hepatitis B
18%
HIV
49%
Hormone Cancer Therapy
18%
Hormone Receptor
6%
Human Immunodeficiency Virus Infection
8%
Human Papillomavirus
16%
Hypoxanthine Phosphoribosyltransferase
6%
Intubation
6%
Lipodystrophy
6%
Liver Cell Carcinoma
31%
Long Term Survival
6%
Lopinavir
8%
Malignant Neoplasm
9%
Maternal Disease
6%
Myelodysplastic Syndrome
6%
Neoplasm
8%
Nevirapine
12%
Papillomavirus Infection
6%
Placebo
6%
Polycyclic Aromatic Hydrocarbon
30%
Prospective Cohort Study
7%
Protein P53
6%
Proteinase Inhibitor
6%
Randomized Clinical Trial
12%
Randomized Controlled Trial
6%
Replacement Therapy
6%
Ritonavir
8%
Stavudine
6%
Uterine Cervix Carcinoma in Situ
6%
Virus Infection
6%
Nursing and Health Professions
Adjuvant Chemotherapy
15%
Antianemic Agent
6%
Aromatase Inhibitor
6%
Breast Cancer
60%
Breast Feeding
7%
Cancer Adjuvant Therapy
13%
Cancer Chemotherapy
6%
Cancer Prevention
6%
Compliance
6%
Confidence Interval
8%
Cryotherapy
7%
Diseases
14%
Gardasil
6%
Hormonal Therapy
16%
Hormone Receptor
8%
Human Immunodeficiency Virus
41%
Liver Cell Carcinoma
6%
Maternal Disease
6%
Medicare
7%
Neoplasm
7%
Nevirapine
6%
Odds Ratio
12%
Oncologist
6%
Papillomavirus Infection
6%
Patient Satisfaction
6%
Patient Social Context
7%
Polycyclic Aromatic Hydrocarbon
6%
Posttraumatic Stress Disorder
6%
Practice Setting
6%
Private Practice
6%
Prospective Cohort Study
7%
Proteinase Inhibitor
6%
Reimbursement
6%
Side Effect
9%
South Africa
13%
Uterine Cervix Cancer
7%
Uterine Cervix Carcinoma in Situ
7%
Weight Loss Program
6%
